Abstract
10,10-Difluoro-13,14-dehydroprostacyclin was compared with natural prostacyclin (prostaglandin I2, PGI2) for vascular relaxing activity in vitro on helical strips of small canine mesenteric arteries (outside diameter < 1 mm) and bovine coronary arteries (outside diameter 1.5-2.5 mm) partially contracted with prostaglanding F2 alpha as well as in vivo in pentobarbital-anesthetized dogs. The difluoro analog was 3- to 4-fold more active than PGI2 in causing relaxation of both types of strips and appeared at least equipotent to PGI2 in its blood pressure lowering effect in dogs. When incubated with Krebs' bicarbonate solution (pH 7.4) at 37 degrees C, the biological half-life of the difluoro analog was about 24 hr compared to the 10- to 15-min half-life of PGI2 under similar conditions. However, when administered intravenously to dogs, the hemodynamic effects of the difluoro analog were of the same duration as those of PGI2.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Crane B. H., Maish T. L., Maddox Y. T., Corey E. J., Székely I., Ramwell P. W. Effect of prostaglandin I2 and analogs on platelet aggregation and smooth muscle contraction. J Pharmacol Exp Ther. 1978 Jul;206(1):132–138. [PubMed] [Google Scholar]
- Dusting G. J., Moncada S., Vane J. R. Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachindonic acid. Prostaglandins. 1977 Jan;13(1):3–15. doi: 10.1016/0090-6980(77)90037-5. [DOI] [PubMed] [Google Scholar]
- Fried J., Lee M. S., Gaede B., Sih J. C., Yoshikawa Y., McCracken J. A. Chemical and biological studies on 13-dehydroprostaglandins. Adv Prostaglandin Thromboxane Res. 1976;1:183–193. [PubMed] [Google Scholar]
- Fried J., Mitra D. K., Nagarajan M., Mehrotra M. M. 10,10-Difluoro-13-dehydroprostacyclin: a chemically and metabolically stabilized potent prostacyclin. J Med Chem. 1980 Mar;23(3):234–237. doi: 10.1021/jm00177a003. [DOI] [PubMed] [Google Scholar]
- McNay J. L., Goldberg L. I. Comparison of the effects of dopamine, isoproterenol, norepinephrine and bradykinin on canine renal and femoral blood flow. J Pharmacol Exp Ther. 1966 Jan;151(1):23–31. [PubMed] [Google Scholar]
- Moncada S., Gryglewski R., Bunting S., Vane J. R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 1976 Oct 21;263(5579):663–665. doi: 10.1038/263663a0. [DOI] [PubMed] [Google Scholar]
- Moncada S., Vane J. R. Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis. Br Med Bull. 1978 May;34(2):129–135. doi: 10.1093/oxfordjournals.bmb.a071482. [DOI] [PubMed] [Google Scholar]
- Nicolaou K. C., Barnette W. E., Gasic G. P., Magolda R. L. 6,9-thiaprostacyclin. A stable and biologically potent analogue of prostacyclin (PGI2) J Am Chem Soc. 1977 Nov 9;99(23):7736–7738. doi: 10.1021/ja00465a070. [DOI] [PubMed] [Google Scholar]
- Whittaker N., Bunting S., Salmon J., Moncada S., Vane J. R., Johnson R. A., Morton D. R., Kinner J. H., Gorman R. R., McGuire J. C. The chemical structure of prostaglandin X (prostacyclin). Prostaglandins. 1976 Dec;12(6):915–928. doi: 10.1016/0090-6980(76)90126-x. [DOI] [PubMed] [Google Scholar]